Perturbing the Normal Level of SIDT1 Suppresses the Naked ASO Effect
Although antisense oligonucleotide (ASO) therapeutics can be taken up by living cells without carrier molecules, a large part of incorporated ASOs are trapped in the endosomes and do not exert therapeutic effects. To improve their therapeutic effects, it would be important to elucidate the mechanism...
Guardado en:
Autores principales: | Masayuki Takahashi, Mineaki Seki, Masayuki Nashimoto, Tomohiro Kabuta |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Hindawi Limited
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6bbd43e111d942ffb5f9e3594e13f4dc |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
DNAzymes, Novel Therapeutic Agents in Cancer Therapy: A Review of Concepts to Applications
por: I. B. K. Thomas, et al.
Publicado: (2021) -
Trans-tail regulation-mediated suppression of cryptic transcription
por: Jungmin Choi, et al.
Publicado: (2021) -
Epigenetic modulation of selected immune response genes and altered functions of T lymphocytes and macrophages collectively contribute to autoimmune diabetes protection
por: Arathi Jayaraman, et al.
Publicado: (2021) -
Editor'den [Editorial] 30. Yilimizi Kutluyoruz [We are celebrating the 30th Anniversary]
por: N. Leyla Acan, et al.
Publicado: (2006) -
The insulin centennial—100 years of milestones in biochemistry
por: Alan D. Attie, et al.
Publicado: (2021)